Furthermore, genetic deletion of nSMase2 entailed decreased levels of Cer and exosomes, glial activation, Aβ42 and amyloid plaques, tau phosphorylation, and improved cognition in an AD 5XFAD animal model [138]. This evidence concerns the gene CBLN1 and Alzheimer disease.